Kinaxis Inc. (TSE:KXS – Get Free Report) Senior Officer Christopher John Blaine Fitzgerald sold 2,177 shares of Kinaxis stock in a transaction on Thursday, March 13th. The stock was sold at an average price of C$156.26, for a total transaction of C$340,172.58.
Kinaxis Price Performance
Shares of TSE:KXS traded up C$3.14 on Friday, hitting C$158.80. The stock had a trading volume of 2,554 shares, compared to its average volume of 89,918. The firm’s 50 day moving average price is C$166.38 and its 200-day moving average price is C$165.20. The company has a debt-to-equity ratio of 12.12, a quick ratio of 2.29 and a current ratio of 1.89. Kinaxis Inc. has a twelve month low of C$132.93 and a twelve month high of C$190.17. The company has a market capitalization of C$3.19 billion, a price-to-earnings ratio of 157.61, a price-to-earnings-growth ratio of 3.60 and a beta of 0.78.
Analysts Set New Price Targets
Separately, CIBC lowered their target price on shares of Kinaxis from C$175.00 to C$170.00 in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Kinaxis currently has an average rating of “Moderate Buy” and a consensus price target of C$192.00.
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
See Also
- Five stocks we like better than Kinaxis
- Manufacturing Stocks Investing
- Market Momentum Shifts, But These 3 Stocks Are Built to Last
- Learn Technical Analysis Skills to Master the Stock Market
- D-Wave Quantum Stock Jumps on “Quantum Supremacy” News
- 3 Healthcare Dividend Stocks to Buy
- How Taiwan Semiconductor’s U.S. Move Could Shift Chipmaking
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.